Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell transplantation for autoimmune disease: progress and problems.

Daniel E Furst1

  • 1UCLA Medical School, Rheumatology Division, Los Angeles, California 98101, USA. defurst@mednet.ucla.edu

Current Opinion in Rheumatology
|May 1, 2002
PubMed
Summary

Stem cell transplantation shows promising initial results for autoimmune diseases like rheumatoid arthritis and lupus. Further research is needed to define patient selection and treatment protocols for optimal outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Seminars in arthritis and rheumatism·2026
Same author

Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium.

Expert review of clinical immunology·2026
Same author

Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases.

Annals of the rheumatic diseases·2026
Same author

Integrated single-cell transcriptomic analysis identifies <i>PF4</i> <sup><i>+</i></sup> <i>/PPBP</i> <sup><i>+</i></sup> megakaryocyte-like granulocytes associated with immune dysregulation in autoimmune diseases.

Biochemistry and biophysics reports·2026
Same author

Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy.

RMD open·2026
Same author

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Seminars in arthritis and rheumatism·2026

Area of Science:

  • Immunology
  • Hematology
  • Rheumatology

Background:

  • Autoimmune diseases such as rheumatoid arthritis, juvenile chronic arthritis, systemic lupus erythematosus, and systemic sclerosis can be debilitating.
  • Stem cell transplantation (SCT) is an emerging therapeutic option for severe autoimmune conditions.
  • The European Bone Marrow Transplant Registry provides valuable data on SCT outcomes.

Purpose of the Study:

  • To review the current status of stem cell transplantation for rheumatoid arthritis, juvenile chronic arthritis, systemic lupus erythematosus, and systemic sclerosis.
  • To provide an overview of SCT for autoimmune diseases using data from a large European registry.
  • To assess initial responses, transplant-related mortality, and identify areas for further research.

Main Methods:

Related Experiment Videos

  • Retrospective analysis of data from the European Bone Marrow Transplant Registry.
  • Inclusion of patients with rheumatoid arthritis (n=43), juvenile chronic arthritis (n=35), systemic lupus erythematosus (n=34), and systemic sclerosis (n=58).
  • Review of initial patient responses and transplant-related mortality.

Main Results:

  • Most patients demonstrated good to excellent initial responses to SCT.
  • Transplant-related mortality was low in rheumatoid arthritis but higher in other conditions, with a trend towards reduction.
  • Patient selection criteria and treatment regimens remain undefined for rheumatoid arthritis and systemic lupus erythematosus.
  • Encouraging responses in juvenile chronic arthritis, but limited published data exist.
  • Controlled trials are ongoing for systemic sclerosis with defined selection criteria and regimens.

Conclusions:

  • Stem cell transplantation is a viable option for autoimmune diseases, with promising initial efficacy.
  • Further standardization of patient selection and treatment protocols is crucial for rheumatoid arthritis and systemic lupus erythematosus.
  • Ongoing research and trials are essential to optimize SCT for juvenile chronic arthritis and systemic sclerosis.